+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Women's Health Market - Global Forecast 2026-2032- Product Image
Women's Health Market - Global Forecast 2026-2032- Product Image
New

Women's Health Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666341
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The women's health market is undergoing rapid transformation as clinical innovation, digital solutions, and shifting care models reshape opportunities for stakeholders. Leading decision-makers need actionable insight to navigate these structural, regulatory, and commercial changes affecting the entire ecosystem.

Market Snapshot: Women's Health Market Size and Growth

The Women's Health Market expanded from USD 51.36 billion in 2025 to USD 55.70 billion in 2026 and is set to accelerate further at a CAGR of 9.26%, reaching USD 95.50 billion by 2032. This robust trajectory underscores sustained interest, investment, and clinical demand across multiple segments, with advances in digital health, remote diagnostics, and therapies influencing how products are commercialized and adopted worldwide.

Scope & Segmentation of the Women's Health Market

This report provides a comprehensive analysis of the evolving women's health landscape, spanning the following areas:

  • Product Categories: Medical devices (e.g., contraceptive and diagnostic tools), pharmaceuticals (fertility, hormonal, pain management therapies), and supplements or nutraceuticals for bone, prenatal, and postnatal health.
  • Distribution Channels: Offline channels such as direct sales, hospital and retail pharmacies; online channels including e-commerce and online pharmacies supporting new access models.
  • Clinical Applications: Fertility enhancement, gynecological procedures, hormonal imbalance treatment, menstrual disorder management, and comprehensive reproductive health solutions.
  • End-User Environments: Clinics, homecare settings, and hospitals, each with unique procurement priorities and workflow needs.
  • Technological Innovations: Digital health, telemedicine, real-time monitoring, precision medicine, biomarker-driven therapies, data analytics, and remote diagnostic platforms.
  • Geographies: Americas, Europe, Middle East & Africa, and Asia-Pacific, with attention to regulatory, reimbursement, commercial, and supply chain distinctions across each.

Key Takeaways for Senior Decision-Makers

  • Patient empowerment and digitization are altering care pathways, requiring integration of devices, therapeutics, and digital platforms for clinical and commercial success.
  • Strategic partnerships among device makers, pharmaceutical companies, digital health firms, and payers accelerate scalable solutions and validate real-world evidence.
  • Supply chain resilience, such as nearshoring and supplier diversification, is essential to mitigate volatility and ensure continuous clinical access amidst tariff changes or trade disruption.
  • Consumer-driven demand for transparency and convenience is lifting over-the-counter, supplement, and direct-to-consumer models, prompting higher evidence standards and clear health claims.
  • Segmentation by channel, clinical application, and end-user allows for precise investment targeting, tailored go-to-market strategies, and maximized product-market fit.
  • Regional differences in regulation, reimbursement, and digital infrastructure require adaptive approaches to evidence generation, market access, and distribution.

Tariff Impact and Evolving Policy Landscape

Tariff shifts are compelling procurement teams and manufacturers to optimize supplier networks, diversify sourcing strategies, and consider localized manufacturing to manage rising import costs. These actions directly affect product availability, care prioritization, and operational resilience across global and regional women's health supply chains. Stakeholders must invest in both immediate risk mitigation and long-term flexibility to protect patient access, maintain continuity, and support financially sustainable growth.

Research Methodology & Data Sources

The report combines secondary research—from clinical literature, industry publications, and regulatory frameworks—with primary interviews involving clinicians, procurement leaders, distributors, and digital innovators. Data triangulation and expert validation workshops ensure that the findings accurately reflect operational realities and market constraints.

Why This Report Matters for the Women's Health Market

  • Enables leaders to benchmark investment strategies against rapidly changing clinical, technological, and regional trends in the women's health space.
  • Supports data-driven, regionally tailored approaches to commercialization, regulatory alignment, and supply chain management for enduring competitive advantage.
  • Identifies actionable pathways to integrate digital innovation, supply resilience, and partnership models for effective market entry and sustained adoption.

Conclusion

Organizations that align operational agility, evidence generation, and patient-centered design are best placed to deliver more accessible and effective women's health solutions. Leadership teams equipped with these market insights can confidently address near-term disruption and secure long-term growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Women's Health Market, by Product
8.1. Medical Devices
8.1.1. Contraceptive Devices
8.1.2. Diagnostic Tools
8.1.3. Pregnancy Monitoring Devices
8.2. Pharmaceuticals
8.2.1. Fertility Medications
8.2.2. Hormonal Drugs
8.2.3. Pain Management
8.3. Supplements & Nutraceuticals
8.3.1. Bone Health
8.3.2. Prenatal & Postnatal Vitamins
9. Women's Health Market, by Distribution Channel
9.1. Offline
9.1.1. Direct Sales
9.1.2. Hospital Pharmacies
9.1.3. Retail Pharmacies
9.2. Online
9.2.1. E-Commerce Platforms
9.2.2. Online Pharmacies
10. Women's Health Market, by Application
10.1. Fertility Enhancement
10.2. Gynecological Procedures
10.3. Hormonal Imbalance Treatment
10.4. Menstrual Disorder Management
10.5. Reproductive Health
11. Women's Health Market, by End User
11.1. Clinics
11.2. Homecare Settings
11.3. Hospitals
12. Women's Health Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Women's Health Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Women's Health Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Women's Health Market
16. China Women's Health Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc.
17.6. Amgen Inc.
17.7. Bayer AG
17.8. CooperCompanies, Inc.
17.9. Endo International plc
17.10. Evofem Biosciences, Inc.
17.11. Ferring Holding SA
17.12. Gedeon Richter Plc
17.13. Hologic, Inc.
17.14. Johnson & Johnson
17.15. Mayne Pharma Group Limited
17.16. Merck & Co., Inc.
17.17. Myovant Sciences Ltd.
17.18. Organon & Co.
17.19. Pfizer Inc.
17.20. Radius Health, Inc.
17.21. Roche Holding AG
17.22. Theramex HQ UK Limited
17.23. TherapeuticsMD, Inc.
17.24. Zambon S.p.A.
List of Figures
FIGURE 1. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES WOMEN'S HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA WOMEN'S HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DIAGNOSTIC TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DIAGNOSTIC TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DIAGNOSTIC TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PREGNANCY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PREGNANCY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PREGNANCY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MEDICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MEDICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY MEDICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY BONE HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY BONE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY BONE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRENATAL & POSTNATAL VITAMINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRENATAL & POSTNATAL VITAMINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY PRENATAL & POSTNATAL VITAMINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY FERTILITY ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY GYNECOLOGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY GYNECOLOGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY GYNECOLOGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL IMBALANCE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL IMBALANCE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL IMBALANCE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL DISORDER MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL DISORDER MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENSTRUAL DISORDER MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REPRODUCTIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REPRODUCTIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. EUROPE WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 132. EUROPE WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 133. EUROPE WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. EUROPE WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. AFRICA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 152. AFRICA WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 153. AFRICA WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 154. AFRICA WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 155. AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. AFRICA WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 157. AFRICA WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 158. AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. AFRICA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 173. ASEAN WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 174. ASEAN WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 175. ASEAN WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 176. ASEAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. ASEAN WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 178. ASEAN WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 179. ASEAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. ASEAN WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. GCC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GCC WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 183. GCC WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 184. GCC WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 185. GCC WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 186. GCC WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 187. GCC WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 188. GCC WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 189. GCC WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. GCC WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. BRICS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. BRICS WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 203. BRICS WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 204. BRICS WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 205. BRICS WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 206. BRICS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. BRICS WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 208. BRICS WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 209. BRICS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. BRICS WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. G7 WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. G7 WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 213. G7 WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 214. G7 WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 215. G7 WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 216. G7 WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. G7 WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 218. G7 WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 219. G7 WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. G7 WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. NATO WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. NATO WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 223. NATO WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 224. NATO WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 225. NATO WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 226. NATO WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. NATO WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 228. NATO WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 229. NATO WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. NATO WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES WOMEN'S HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. CHINA WOMEN'S HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. CHINA WOMEN'S HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 244. CHINA WOMEN'S HEALTH MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 245. CHINA WOMEN'S HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 246. CHINA WOMEN'S HEALTH MARKET SIZE, BY SUPPLEMENTS & NUTRACEUTICALS, 2018-2032 (USD MILLION)
TABLE 247. CHINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. CHINA WOMEN'S HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 249. CHINA WOMEN'S HEALTH MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 250. CHINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. CHINA WOMEN'S HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Women's Health market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • CooperCompanies, Inc.
  • Endo International plc
  • Evofem Biosciences, Inc.
  • Ferring Holding SA
  • Gedeon Richter Plc
  • Hologic, Inc.
  • Johnson & Johnson
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Myovant Sciences Ltd.
  • Organon & Co.
  • Pfizer Inc.
  • Radius Health, Inc.
  • Roche Holding AG
  • Theramex HQ UK Limited
  • TherapeuticsMD, Inc.
  • Zambon S.p.A.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 55.7 Billion
Forecasted Market Value ( USD ) by 2032 $ 95.5 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Womens Health Consumer Products Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Womens Health Consumer Products Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 250 Pages
  • Global
From
Women Health Supplement Market - Global Forecast 2026-2032 - Product Image

Women Health Supplement Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Women's Digital Health Market - Global Forecast 2026-2032 - Product Image

Women's Digital Health Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Premenstrual Syndrome Treatment Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Premenstrual Syndrome Treatment Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Women's Health Market

The Women's Health market is a sector of the healthcare industry that focuses on the health and wellness of women. It includes products and services that are designed to meet the unique needs of women, such as contraception, fertility treatments, and menopause management. It also includes products and services that are designed to improve the overall health and wellbeing of women, such as nutrition, exercise, and mental health. The Women's Health market is growing rapidly, driven by increasing awareness of the importance of women's health and wellness, as well as advances in technology and healthcare. Companies in this market include pharmaceutical companies, medical device manufacturers, health and wellness companies, and digital health companies. Examples of companies in this market include Bayer, Merck, Pfizer, Novo Nordisk, and Sanofi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.